V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160009060 | 160008826 | 1.76 | 17.4 | Palliative (P) | null | null | Pemetrexed | N | null | DOXORUBICIN + IFOSFAMIDE | 100676140 |
| 160009157 | 160008828 | null | null | Neo-adjuvant (N) | 2017-10-31 | 2017-11-20 | CARBOPLATIN + PACLITAXEL | null | null | LIPOSOMAL DOXORUBICIN | 101445300 |
| 160009384 | 160008829 | 1.61 | 70 | Palliative (P) | 2019-12-26 | 2020-01-18 | Ifosfamide + Liposomal Doxorubicin | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101177507 |
| 160009395 | 160008830 | 1.79 | 61.2 | Palliative (P) | 2018-05-18 | 2018-06-04 | Carboplatin AUC 2 - 5 | 02 | N | TRIAL UNSPECIFIED | 100169012 |
| 160009476 | 160008831 | 1.8 | 91 | Palliative (P) | 2018-12-28 | 2018-12-30 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100784347 |
| 160009516 | 160008832 | null | null | Palliative (P) | 2017-09-09 | 2017-09-16 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101013768 |
| 160009642 | 160008835 | 0 | 9.3 | Palliative (P) | 2019-12-03 | 2019-12-14 | PARTNER Trial | 02 | N | CISPLATIN + PACLITAXEL | 100550420 |
| 160009659 | 160008836 | 1.69 | 57 | Palliative (P) | 2016-09-19 | 2016-09-19 | Liposomal Doxorubicin (Caelyx) | N | N | IFOSFAMIDE | 100847086 |
| 160009721 | 160008837 | 1.55 | 59 | Neo-adjuvant (N) | null | 2019-06-02 | Doxorubicin + Ifosfamide | 02 | N | DOCETAXEL + GEMCITABINE | 101109483 |
| 160009742 | 160008838 | 1.8 | 82.7 | Curative (C) | 2017-12-02 | 2017-12-09 | Liposomal Doxorubicin (Caelyx) | 02 | N | DOCETAXEL + GEMCITABINE | 101683016 |
| 160009781 | 160008839 | 1.54 | 52.7 | Adjuvant (A) | 2018-12-06 | 2018-12-06 | DOXORUBICIN + IFOSFAMIDE | 02 | N | EW EUROEWING 2012 ARM B VDC | 100167793 |
| 160009800 | 160008840 | 1.8 | 52.4 | null | 2016-04-18 | 2016-04-19 | Doxorubicin 75mg/m2 | 02 | Y | DOXORUBICIN | 100706611 |
| 160010066 | 160008843 | 1.61 | 71.3 | Palliative (P) | 2018-09-26 | 2018-09-28 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 100927792 |
| 160010093 | 160008844 | 1.71 | 58.4 | Palliative (P) | null | 2016-03-25 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101365142 |
| 160010151 | 160008845 | 1.71 | 119.9 | Palliative (P) | 2018-05-27 | 2018-06-01 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100237670 |
| 160010269 | 160008847 | 1.61 | 51.8 | Palliative (P) | 2018-02-07 | 2018-02-15 | Doxorubicin + Ifosfamide | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100684796 |
| 160010360 | 160008848 | 1.71 | 79.8 | null | 2016-11-04 | 2016-11-05 | Liposomal Doxorubicin (Caelyx) | N | N | TRIAL | 100726315 |
| 160010408 | 160008849 | 0 | 58 | Palliative (P) | 2017-07-01 | 2017-07-03 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101861151 |
| 160010413 | 160008850 | 0 | 13.9 | Palliative (P) | 2017-10-15 | 2017-10-15 | DOXORUBICIN | N | N | DOXORUBICIN | 101436418 |
| 160010429 | 160008851 | 1.67 | 119 | null | 2019-06-28 | 2019-06-28 | Doxorubicin + Ifosfamide | 02 | Y | LIPOSOMAL DOXORUBICIN | 100529334 |
| 160010475 | 160008852 | 1.74 | 80 | null | 2018-12-16 | 2018-12-16 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100519514 |
| 160010514 | 160008853 | 1.78 | 63.5 | Curative (C) | 2018-05-23 | 2018-06-17 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | STS RHABDOMYOSARCOMA RMS 2005 IVADO | 100292842 |
| 160010558 | 160008854 | 1.72 | 67.3 | Palliative (P) | 2019-01-01 | 2019-01-23 | Trabectedin | 02 | N | CTD | 100888364 |
| 160010630 | 160008855 | null | 16.8 | null | null | 2019-03-31 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100500526 |
| 160010731 | 160008856 | 1.6 | 79 | Disease modification (D) | 2018-08-02 | 2018-09-10 | Doxorubicin + Olaratumab | N | N | BEVACIZUMAB + CARBO + PACLITAXEL | 100934293 |
| 160010801 | 160008858 | 1.56 | 66.4 | Neo-adjuvant (N) | 2016-06-20 | 2016-07-11 | Doxorubicin + Olaratumab | N | N | LIPOSOMAL DOXORUBICIN | 100508709 |
| 160010878 | 160008860 | 1.63 | 64.5 | null | 2018-07-06 | 2018-07-09 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 100573206 |
| 160010902 | 160008861 | 1.86 | 61.5 | Neo-adjuvant (N) | 2019-07-04 | 2019-07-24 | Doxorubicin + Ifosfamide | null | N | OCTREOTIDE | 101515224 |
| 160010938 | 160008862 | 1.74 | 64 | Palliative (P) | 2017-10-16 | 2017-10-22 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101163903 |
| 160011166 | 160008863 | 1.63 | 84.5 | Palliative (P) | 2019-05-09 | 2019-05-09 | Trial Unspecified | 02 | null | ENZALUTAMIDE | 101542759 |
| 160011170 | 160008864 | 1.75 | 106.4 | null | 2019-12-15 | 2019-12-16 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100199392 |
| 160011185 | 160008865 | 1.83 | 58 | null | 2018-10-25 | 2018-10-25 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100711398 |
| 160011223 | 160008866 | 1.52 | 80.2 | Neo-adjuvant (N) | 2019-10-11 | 2019-10-12 | Carboplatin AUC 2 - 5 | N | null | CARBOPLATIN | 101405250 |
| 160011313 | 160008867 | 1.56 | 70 | Palliative (P) | 2018-06-22 | 2018-06-28 | Liposomal Doxorubicin (20mg/m2) | 02 | N | ICON9 TRIAL | 100079327 |
| 160011320 | 160008868 | 1.6 | 59 | Neo-adjuvant (N) | 2017-10-18 | 2017-10-18 | Carboplatin + Paclitaxel (3 weekly) | 01 | N | CARBOPLATIN + PACLITAXEL | 101746287 |
| 160011377 | 160008869 | 1.61 | 10.9 | Palliative (P) | 2020-04-21 | 2020-04-23 | Epirubicin (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100726833 |
| 160011483 | 160008872 | 1.64 | 74.8 | Palliative (P) | null | 2018-01-03 | GemCarbo Days 1+8 | Y | N | CISPLATIN + GEMCITABINE | 100140198 |
| 160011501 | 160008873 | 1.79 | 59.2 | 03 | 2018-12-21 | 2019-01-16 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100685188 |
| 160011547 | 160008874 | 1.72 | 66.3 | null | 2018-10-24 | 2018-11-01 | Doxorubicin + Ifosfamide | N | N | BEP | 100241160 |
| 160011663 | 160008876 | 1.58 | 58.3 | Curative (C) | 2018-08-02 | 2018-08-12 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101390114 |
| 160011718 | 160008877 | 1.78 | 79 | Palliative (P) | 2019-07-21 | 2019-08-06 | CARBOPLATIN + PACLITAXEL | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 101062526 |
| 160011782 | 160008878 | 1.67 | 128 | Palliative (P) | 2017-10-26 | 2017-10-28 | BEVACIZUMAB + CARBO + PACLITAXEL | null | N | DOCETAXEL | 101612656 |
| 160011895 | 160008879 | 1.78 | 67.4 | Palliative (P) | 2019-02-22 | 2019-02-24 | Doxorubicin + Ifosfamide | N | N | PACLITAXEL | 101049355 |
| 160011962 | 160008880 | 1.61 | 70.9 | Curative (C) | 2017-06-29 | 2017-07-06 | Bevacizumab+Carbo+Pacliaxel | 2 | N | CARBOPLATIN + PACLITAXEL | 100667890 |
| 160011979 | 160008881 | 1.45 | 46.8 | Palliative (P) | 2018-12-16 | 2018-12-28 | Doxorubicin + Ifosfamide | 02 | N | TRIAL | 100778251 |
| 160012064 | 160008882 | 1.71 | 58.1 | Palliative (P) | 2019-12-05 | 2019-12-12 | DOXORUBICIN | N | N | DOXORUBICIN | 101487150 |
| 160012068 | 160008883 | 1.71 | 50 | Palliative (P) | 2019-06-22 | 2019-07-06 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101598329 |
| 160012150 | 160008884 | 1.78 | 70 | Neo-adjuvant (N) | 2018-11-24 | 2018-12-14 | EW EuroEwing 2012 Arm B VDC | 02 | N | LENALIDOMIDE | 100388806 |
| 160012281 | 160008885 | 1.8 | 77 | Neo-adjuvant (N) | 2018-12-04 | 2018-12-09 | null | 02 | N | TRIAL UNSPECIFIED | 101765114 |
| 160012366 | 160008886 | 0 | 58 | Palliative (P) | 2017-08-08 | 2017-08-19 | Carboplatin + Paclitaxel (weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100358644 |